lycorine has been researched along with Pancreatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Huang, X; Li, X; Liu, J; Liu, Y; Meng, M; Qi, J; Song, X; Wang, X; Zhao, Z; Zhou, Q; Zhou, Z | 1 |
| Chen, Z; Guo, Z; Li, X; Liu, S; Ma, K; Wang, Y; Yang, R; Zhou, X | 1 |
2 other study(ies) available for lycorine and Pancreatic Neoplasms
| Article | Year |
|---|---|
Lycorine inhibits pancreatic cancer cell growth and neovascularization by inducing Notch1 degradation and downregulating key vasculogenic genes.
Topics: Amaryllidaceae Alkaloids; Animals; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Humans; Mice; Oncogene Proteins; Pancreatic Neoplasms | 2023 |
Transcriptomics and molecular docking reveal the potential mechanism of lycorine against pancreatic cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Fatty Acids; Mice; Molecular Docking Simulation; Pancreatic Neoplasms; RNA, Small Interfering; Transcriptome | 2024 |